Loading clinical trials...
Loading clinical trials...
Evaluate the safety and efficacy of microcurrent stimulation therapy for patients with dry age-related macular degeneration.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
i-Lumen Scientific, Inc.
NCT06557460 · Dry Age-related Macular Degeneration, Geographic Atrophy
NCT04627428 · Dry Age-related Macular Degeneration
NCT06165068 · Dry Age-related Macular Degeneration
NCT05797896 · Dry Age-related Macular Degeneration, Geographic Atrophy, and more
NCT07424235 · Age Related Macular Degeneration (AMD), Age Related Macular Degeneration, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions